期刊
ISCIENCE
卷 24, 期 11, 页码 -出版社
CELL PRESS
DOI: 10.1016/j.isci.2021.103282
关键词
-
资金
- Dutch Technology Foundation TTW, Netherlands Organization for Scientific Research (NWO)
- Ministry of Economic Affairs
- Dutch Huntington Stimulation Grant 2013
- Campaign Team Huntington in The Netherlands
- de Cock-Hadders Stichting grant
- NAMASTE scholarship - Erasmus Mundus India-EU mobility consortium
DNAJB6 delivered through sEVs effectively inhibits polyQ aggregation in vitro and in vivo, significantly reducing mutant HTT aggregation in the brains of R6/2 transgenic HD mice and potentially delaying disease onset.
Huntington disease (HD) is a devastating neurodegenerative disorder characterized by aggregation of huntingtin (HTT) protein containing expanded polyglutamine (polyQ) tracts. DNAJB6, a member of the DNAJ chaperone family, was reported to efficiently inhibit polyQ aggregation in vitro, in cell models, and in vivo in flies, xenopus, and mice. For the delivery of exogenous DNAJB6 to the brain, the DNAJB6 needs to be protected against (enzymatic) deg: Jation and show good penetration into brain tissue. Here, we tested the potential of small extracellular vesicles (sEVs) derived from neural stem cells (NSCs) for delivery of DNAJB6 as anti-amyloidogenic cargo. Administration of sEVs isolated from DNAJB6-overexpressing cells to cells expressing expanded polyQ tracts suppressed HTT aggregation. Furthermore, intrathecal injection of DNAJB6-enriched sEVs into R6/2 transgenic HD mice significantly reduced mutant HTT aggi lgation in the brain. Taken together, our data suggest that sEV-mediated molecular chaperone delivery may hold potential to delay disease onset in HD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据